Genetic variant may raise risk for diabetes and cardiovascular disease

A genetic variant may raise a family doctor’s suspicions about diabetes and risk for cardiovascular disease, according to new findings.
The determination arose from a family history of heart disease in a person whose parents tested positive for the N-nitrosodimorphous protein dificusate, which carries a genetic mutation linked to the development of vascular diseases including diabetes and atherosclerosis, according to researchers.
Intriguingly, the mutation affected the presence of amino acids at a certain residues of dificusate protein.

Birth Control, Global health‎, Nutrition

Study Shows Benefits of a Low Dose Aspirin Toxin

A UCLA-led study found that a low dose of a commonly prescribed dose of aspirin delivered in a single session led to a significant reversal of congestive heart failure, improving quality of life among 54 percent of study participants.
To reach these conclusions, the team conducted a trial with 954 participants determined to test the effect of a low dose aspirin treatment delivered on a single time point (1500 mg/d) among 54 patients.
The researchers found a significant decline in the time to the first episode of chest pain (time to 2-4 weeks after starting aspirin treatment) with a low-dose aspirin treatment.
Another incidental finding was that healthy people who had no chest pain and did not have congestive heart failure were more likely to stop or reduce doses.